Activation of PAR-2 enhances ICAM-1 expression and IL-8 release in airway epithelial cells Source: Eur Respir J 2002; 20: Suppl. 38, 571s Year: 2002
Estrogen protects against airway inflammation via upregulation of SLPI and downregulation of IL-33 Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012
Matrix metalloproteinase inhibitor regulates inflammatory cells migration through reducing ICAM-1 and VCAM-1 expression in a murine model of toluene diisocyanate-induced asthma Source: Eur Respir J 2003; 22: Suppl. 45, 483s Year: 2003
Characterisation of endogenous IL-33 using a model of Alternaria -induced pulmonary inflammation Source: Annual Congress 2012 - Cellular signalling mechanisms in the airways Year: 2012
Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression Source: Eur Respir J 2003; 22: 290-297 Year: 2003
High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients: a reflection of an enhanced immunological function Source: Eur Respir J 2006; 28: 113-122 Year: 2006
A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002
Increased expression of Lipocalin2 suppresses allergen-induced airway disease in mice Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008
Altered expression of adhesion molecules in circulating neutrophils of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 479s Year: 2002
Vascular cell adhesion molecules-1 expression changes in lipopolysaccharide initiated pulmonary inflammation in endotoxin tolerance rats Source: Eur Respir J 2005; 26: Suppl. 49, 406s Year: 2005
TLR-4 downregulation in COPD impairs cytokine release from monocytes and Th1-lymphocytes in response to bacterial endotoxin Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009
LPS-induced TLR4 expression and cytokine release is impaired in monocytes and T-lymphocytes of COPD patients Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD Year: 2008
c-Met expression induction in immune cells modulates pulmonary fibrosis progression Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020
IL-33 may augment the effect of rhinovirus HRV16 on the inflammatory activity of human lung vascular endothelium – possible implication for asthma exacerbations. Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021
IL-33 augments rhinovirus-induced type 2 immune responses in asthma via selective upregulation of one chain of the IL-33 receptor. Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017
P-selectin expression in chronic allergic airway inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 271s Year: 2001
Elevated integrin ?5 expression in idiopathic pulmonary fibrosis (IPF) derived fibroblasts is linked to paracrine TNF-a signaling Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis Year: 2017
Corticosteroids inhibit perivascular recruitment of IL-6 producing cells, maintain BMPR-II pulmonary expression and prevent pulmonary hypertension in monocrotalin-exposed rats Source: Eur Respir J 2007; 30: Suppl. 51, 347s Year: 2007
A role for the CXCL12 receptor, CXCR7, in the pathogenesis of human pulmonary vascular disease Source: Eur Respir J 2012; 39: 1415-1424 Year: 2012
The upregulation of CD-11B expression on circulating neutrophils by CXCL8 and the involvement of CXCR1 in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 749s Year: 2006